The company is currently operating in stealth mode.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Angel (individual) | 08-Apr-2016 | $133K | 00000 | Completed | Stealth |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Michael Altman | Chief Executive Officer, President and Co-Chairman | ||
David Weinstein | Executive and Board Member |
Name | Representing | Role | Since |
---|---|---|---|
David Weinstein | RiverTown Therapeutics | Executive and Board Member | 000 0000 |
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 000 | 000000000000000000 | Drug Discovery | 00000 000000000 |